ArticleEJIFCC2025
Analyzing the Utility of Pooled Sera as Internal Quality Control for Immunoassay Parameters by an EWMA-backed Statistical Mechanism (e-PSQC): A Comparison with Commercially Available Material and Westgard Rules.
Article in EJIFCC, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Internal Quality Control (IQC) is a cornerstone of clinical laboratory operations, ensuring reliability in diagnostic testing. Commercial IQC materials, though effective, pose challenges of high cost, limited availability, and susceptibility to matrix effects. Pooled sera (PS), derived from discarded patient samples, offer a cost-effective alternative. However, the stability and performance of pooled sera as IQC material in immunoassays need robust evaluation, particularly when combined with advanced statistical tools like Exponentially Weighted Moving Average (EWMA). Objective: To evaluate the utility of pooled sera as IQC material for immunoassay parameters using the EWMA statistical approach and compare its performance against commercially available IQC materials. Method: A study was conducted in the clinical biochemistry laboratory at AIIMS Bhubaneswar. Pooled sera were prepared from discarded patient samples, aliquoted, and stored at -5°C. Five immunoassay parameters (Free T3, Free T4, TSH, Cortisol, and Ferritin) were monitored over 60 days using both pooled sera and commercial IQC materials. EWMA charts with a 7-day smoothing window were employed to assess error detection. Performance metrics, including Mean Squared Error (MSE), Root Mean Squared Error (RMSE), and Concordance Correlation Coefficient (CCC), were analyzed. Statistical significance was set at p<0.05. Results: The EWMA analysis of pooled sera (ePSIQC) closely mirrored commercial IQC performance. Concordance was significant for all parameters except Free T4. The ePSIQC method demonstrated superior early error detection compared to traditional Westgard Multirules. Pooled sera remained stable throughout the study duration, with deviations observed only in a few instances. Conclusion: Pooled sera, combined with EWMA, provides a cost-effective, stable, and reliable alternative to commercial IQC materials for immunoassays. The enhanced error detection capability of EWMA strengthens laboratory quality control, offering a viable solution for resource-limited settings.
Indexed as
Identifiers
41459186PMC12743331What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.